Rosacea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Those who voluntarily participate in this trial, have signed the informed consent form, and are able to use the trial products as required and complete the follow-up; 2. Chinese subjects aged between 18 and 60 years old; 3. Patients diagnosed with erythematotelangiectatic rosacea (ETR) in clinical terms; Those who meet all the above requirements can be included.
Exclusion criteria
Exclusion criteria: 1. Those with other inflammatory skin diseases or wounds on the face that make skin sampling inappropriate; 2. Those who have a known history of allergy to any component of the research product; 3. Those who are currently receiving medication that may interfere with the research results; 4. Those with severe systemic diseases, including tumors, bleeding tendencies and coagulation disorders, or those with concurrent liver, cardiovascular and other diseases, or those who have a history of thrombosis or cerebral ischemia; 5. Pregnant, potential pregnant or lactating women or those who have been postpartum for less than half a year; 6. Patients who are currently participating in other clinical studies or have participated in other clinical studies within the past 1 month; 7. Those who the researchers consider not suitable for inclusion; Any individuals meeting any of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin current sensation threshold;Rosacea clinical scorecard; | — |
Secondary
| Measure | Time frame |
|---|---|
| Water content of stratum corneum;Transepidermal Water Loss;Skin color;Capsaicin pricking test;Lactic acid sting test; | — |
Countries
China
Contacts
Peking University First Hospital